Sirt7 associates with ELK1 to participate in hyperglycemia memory and diabetic nephropathy via modulation of DAPK3 expression and endothelial inflammation
Autor: | Xue Li, Jing Liu, Lihong Lu, Ting Huang, Wenting Hou, Fei Wang, Lang Yu, Fengfeng Wu, Jie Qi, Xiangyuan Chen, Zhipeng Meng, Minmin Zhu |
---|---|
Rok vydání: | 2022 |
Předmět: |
Inflammation
Biochemistry (medical) Insulins Public Health Environmental and Occupational Health Endothelial Cells General Medicine Rats Death-Associated Protein Kinases Glucose Hyperglycemia Physiology (medical) Diabetes Mellitus Animals Humans Sirtuins Diabetic Nephropathies ets-Domain Protein Elk-1 |
Zdroj: | Translational Research. 247:99-116 |
ISSN: | 1931-5244 |
DOI: | 10.1016/j.trsl.2022.04.005 |
Popis: | Diabetic nephropathy (DN) is one of the most serious complications of advanced diabetes, and increases patient mortality. Recently, epigenetics-mediated hyperglycemic memory in pathological process of DN has received attention. The purpose of this study was to determine the underlying mechanism by which sirt7 modulates hyperglycemic memory in DN. In glomerular endothelial cells (GECs) cultured in high glucose and glomeruli of DN patients and rats, an increase in p65 phosphorylation and endothelial adhesion molecule levels persisted after glucose normalization but was reversed by glucose normalization associated with death-associated protein kinase-3 (DAPK3) knockout or DAPK3 inhibitor. High glucose-mediated decrease in sirt7, the deacetylase modulating H3K18-acetylation (H3K18ac), was sustained after normoglycemia. Sirt7 overexpression accompanied by glucose normalization suppressed DAPK3 expression and inflammation in GECs. Moreover, sh-sirt7-induced inflammation was inhibited by si-DAPK3. Furthermore, sirt7 and H3K18ac were located at the DAPK3 promoter region. ELK1 was found to combine with sirt7. si-ELK1 supplemented with normoglycemia inhibited high glucose-induced DAPK3 expression and inflammation in GECs. ELK1 overexpression-mediated inflammation was inhibited by si-DAPK3. In addition, ELK1 and sirt7 were located at the same promoter region of DAPK3. ELK1 overexpression enhanced DAPK3 promoter activity, which disappeared after specific binding site mutation. In vivo, sirt7 overexpression decreased inflammation and improved renal function during insulin treatment of DN rats, whereas insulin alone did not work. Our data demonstrated high glucose-mediated mutual inhibition between sirt7 and ELK1 induced DAPK3 transcription and inflammation despite normoglycemia in GECs, thus forming a vicious cycle and participating in the occurrence of hyperglycemic memory in DN. |
Databáze: | OpenAIRE |
Externí odkaz: |